+34 620 10 75 37info@nanbiosis.com

Posts Taged nanoimaging

Wide representation of NANBIOSIS research in NALS 2022 and best Oral Presentation to Eloi Parladé

During the last 27-29 April, the 3rd International Conference on Nanomaterials Applied to Life Sciences 2022 (NALS 2022) has taken place in the Excellence Campus of Universidad de Cantabria in Santander (Spain), organized by the University of Cantabria and Institute Valdecilla-IDIVAL.

NALS 2022 has been a multidisciplinary conference series sharing new results and ideas in the fields of biosensors, lab on a chip, drug delivery nanopharmacy. nanobiotechnology, intelligent nanomaterials, magnetic materials, nanotoxicity, antimicrobials, novel applications of 3d bioprinting and nanoimaging.

NANBIOSIS has been represented at this edition by members of several of its units, among them we must highlight the set of four oral communication presented by members of the Nanobiotechnology group-Unit 1 of NANBIOSIS “Protein Production Platform (PPP)”, from CIBER-BBN and IIB-UAB the talks were delivered by:

Eloi Parladé: “Development of ion-dependent microscale secretory granules for nanomedical applications

Carlos Martínez-Torró: “Design of a human GFP-like protein scaffold for targeted nanomedicines

Eric Voltá Durán: “Antitumoral nanoparticles with multiple activities, a close reality

Jan Atienza-Garriga: “Characterization of protein-only NPs containing amps and analysis of their protection with liposomes and micelles

They summarized a wide area of the team activities on the design of protein-based protein materials for clinical uses, produced by means of diverse types of cell factories. In particular, antimicrobial peptides, cytotoxic proteins with antitumoral targeting and drug-carrying scaffold proteins are engineered to confer self-assembling properties as either microparticles or nanoparticles, that can be further functionalized with chemical drugs through covalent binding. Microparticles are of special interest as they can be used as slow drug delivery systems for nanostructured drugs upon subcutaneous administration. Alternatively, nanoparticles can be also presented as embedded in liposomes or other micellar structures that stabilize them for enhanced performance.

Three NANBIOSIS units supported the presented research, which has been executed in a highly cooperative way: namely U1 (Protein Production Platform), led by Tony Villaverde U18 (Nanotoxicology), led by Ramón Mangues and U29 (Oligonucleotide Synthesis Platform), led by Ramón Eritja.

Among all the excellent contributions by the team, it is worthy to stress that the prize for the best Oral Presentation was granted to Dr Eloi Parladé.

Other talk by researchers from NANBIOSIS were “Antioxidant-loaded polymeric NPs prepared by nano-emulsion templating for the management of neurological diseases” by Santiago Grijalvo, from NANBIOSIS U12 and  “Exploiting GSH oxidation with nanocatalysts to promote cancer cell death” by Javier Bonet-Aletá from NANBIOSIS U9

On the other hand, Jesús Santamaría,  Scientific Director of NANBIOSIS U9 was a Keynote Speaker in the Conference with the talk: “A change of paradigm in cancer therapy? Using catalysts to make drugs inside the tumor, rather than trying systemic chemotherapy”

NALS 2022 has been an excellent conference, with presentations covering a wide range of topics in nanomaterials for health, and a great opportunity for our researchers, especially for young’s, to let know their collaborative work, as well as make new connections on common research interests, thanks to the good socializing opportunities afforded by the scheduling of the organization conference.

Read More

BIONAND incorporated to the Spanish ICTS Map as a new node of NANBIOSIS

The Scientific, Technological and Innovation Policy Council (CPCTI) of the Spanish Ministry of Science, Innovation and Universities has recently approved the updating of the National ICTS Map (Unique Scientific Technological Infrastructures). ICTS are large installations, resources, facilities and services, unique in its kind, that are dedicated to cutting edge and high-quality research and technological development, as well as to promote exchange, transmission and preservation of knowledge, technology transfer and innovation.

After the evaluation by the CPCTI of the ICTS activity during the last four years, NANBIOSIS maintains its presence in the new National ICTS Map, but it introduces a novelty compared to the prior one. NANBIOSIS, initially formed by CIBER-BBN and CCMIJU, incorporates BIONAND as new node, which has been included in the Strategic Master Plan for the next four years.

NANBIOSIS is the ICTS that provide a complete integrated cutting-edge biomedical advance solutions for companies and research institutions under a single contact point through the design and production of biomaterials, nanomaterials and their nanoconjugates, its characterization from a physic-chemical, functional, toxicological and biological (preclinical validation) point of view, focused on biomedical applications such as: IVDs, medical devices, biosensors, regenerative medicine, drug delivery systems, therapeutic agents or MRI contrast agents.

The incorporation of BIONAND to NANBIOIS supposes for the ICTS the possibility of amplifying its capacities and in particular to complete and expand its offer of cutting-edge biomedical solutions.

BIONAND, located in the Technological Park of Andalusia and directed by Professor José Becerra Ratia of the University of Málaga (UMA), is a mixed character center participated by the University of Malaga and by the Andalusian Government, conceived as a space for excellence research in nanomedicine that has scientific infrastructures with unique avant-garde equipment, among which, the Nano-Imaging Unit, incorporated to NANBIOSIS, stands out.

BIONAND’s Nanoimaging Unit brings together a wide range of cutting-edge technologies, including high-field magnetic resonance imaging and spectroscopy, micro-CT, PET, SPECT, intra-vital optical imaging, electron microscopy, advanced optical microscopy, cell sorting and high content screening. The unit has been conceived and optimized to provide very diverse and integrated technological support for nanotechnology-based biomedical research, offering advance services to internal and external users.

The Nano-Imaging unit, headed by Dr. María Luisa García Martín, is a powerful last-generation of preclinical imaging facility that offers the possibility of acquiring micro and nano-scale images through a wide variety of techniques.

Dr. María Luisa García presented BIONAND as the new node of NANBIOSIS on November 12 in the session dedicated to NANBIOSIS that took place at the annual Scientific Conferences of CIBER-BBN.

In addition, last November 14, Dr José Becerra, represented NANBIOSIS in the General Assembly of Materplat, giving a talk about the “Customization of Implants and their biological function”. Further information

NANBIOSIS is working in the integration of the new node of BIONAND on the website and offer of NANBIOSIS

Read More